The First ED Nasal Spray Arrives in 2026: What Roxus Means for Men Weighing Their Options

Roxus is intranasal vardenafil — the same active ingredient as Levitra, a PDE5 inhibitor in the same drug class as sildenafil (Viagra) and tadalafil (Cialis). Instead of being swallowed and absorbed through the digestive tract, it is sprayed into the nose, where the medication crosses the nasal lining directly into the bloodstream.

That delivery route is the entire point. According to the company's October announcement, Roxus reaches peak blood levels in a median of about 10 minutes, compared with 45 to 60 minutes for vardenafil tablets — using roughly a quarter of the tablet dose. Oral ED pills are absorbed more slowly, and a heavy or fatty meal can delay them further. A spray that bypasses the stomach sidesteps both problems, which is why the company frames the product around spontaneity.

Roxus is the U.S. version of SPONTAN, the same formulation LTR Pharma has offered in Australia for about two years through that country's special access pathway. In the U.S., it is available nationwide by prescription, compounded and dispensed through a single partner pharmacy.

The published evidence behind Roxus is real but small. In a Phase 1 crossover study of 19 men published in 2025, a 5 mg intranasal dose reached peak concentration at a median of about 10 minutes, versus about 45 minutes for a 10 mg oral tablet. A Phase 2 pharmacokinetic study reported in October 2026 — 27 men, 14 of them aged 65 and older — found the same roughly 10-minute median, versus 60 minutes for a 20 mg tablet, with no serious adverse events reported. Notably, older men absorbed the spray just as quickly, which matters because ED becomes more common with age.

The company has also described real-world results from 147 Australian men using SPONTAN, reporting improvement in 68% overall — including 57% of men who had responded poorly to oral tablets. That study is still under peer review.

Keep the limitations in view. These are small pharmacokinetic studies measuring how fast the drug gets into the blood, not large head-to-head trials measuring erections, satisfaction, or safety against sildenafil or tadalafil — no such comparison trial has been run. The real-world data is self-reported and not yet peer reviewed. Faster absorption is plausible grounds for faster onset, but the strength of evidence here is nowhere near what stands behind the established pills, which have been studied in tens of thousands of men over nearly three decades.

This is the detail many headlines skip: Roxus is not an FDA-approved product. It is a compounded medication, prepared under Section 503A of federal law for individual patients with a valid prescription, and the FDA has not reviewed it for safety or efficacy. The approved version — SPONTAN — is working through the FDA's 505(b)(2) pathway toward a planned Phase 3 study, which means a fully approved ED nasal spray is likely years away, if the trials succeed.

Compounded does not mean illegitimate; compounding pharmacies fill real clinical gaps every day, and vardenafil itself is a well-characterized, FDA-approved molecule in tablet form. But it does mean the specific spray formulation, dose consistency, and nasal delivery have not passed the FDA review that Viagra, Cialis, Levitra, and their generics all did. If you have followed the compounded semaglutide story in weight loss, the trade-off is familiar: earlier access, less regulatory assurance. That is a decision to make with a licensed provider, not a marketing page.

For most men starting ED treatment, the practical comparison looks like this. Sildenafil typically starts working in 30 to 60 minutes and lasts around four hours — the most prescribed, most studied option, available as an inexpensive generic. Tadalafil takes a similar time to kick in but lasts up to 36 hours, and a low daily dose removes timing from the equation entirely — many men find that solves the spontaneity problem the nasal spray is chasing, at generic-tablet prices. Roxus, by contrast, offers the fastest absorption of the three in early studies, but with limited evidence, no FDA approval, availability through one compounding channel, and no published price advantage; generic tablets can cost just a few dollars a dose, and a niche compounded product is unlikely to compete on cost.

Side effects are broadly similar across the class: headache, flushing, congestion, and indigestion are the common ones, and the spray adds temporary nasal irritation. The hard safety rules also carry over — no PDE5 inhibitor is safe with nitrate medications or riociguat, caution applies with alpha-blockers and significant heart, liver, or kidney disease, and an erection lasting more than four hours or any sudden vision or hearing loss is an emergency. ED itself can be an early warning sign of cardiovascular disease — one more reason the right first step is a medical evaluation, not the newest product.

The honest answer: a specific minority, at least for now. The company's own estimate is that 30–35% of men do not respond adequately to oral PDE5 inhibitors, and its Australian real-world data showed the strongest results in men who wanted faster onset, men recovering after prostate surgery, and some men who had failed tablets. Men who find the 30-to-60-minute wait disruptive — or whose results vary with meals — are the plausible audience. If generic sildenafil or tadalafil already works for you, the early data gives no reason to switch to a less-studied, unapproved formulation. If tablets have failed you, that is worth a conversation with a provider — about dosing, daily tadalafil, underlying causes, and perhaps newer delivery routes as the evidence matures.

The arrival of an ED nasal spray is a reminder of how fast this category is moving — but the best treatment is still the one matched to your health, your pattern of symptoms, and your budget by a licensed clinician. JoeyMed's sexual health service connects you with a licensed provider online who reviews your health history, screens for interactions and cardiovascular red flags, and, when appropriate, prescribes proven generic sildenafil or tadalafil — shipped discreetly to your door at a fraction of brand-name prices. If ED has been the thing you keep putting off, a short online visit is an easy first step, and your provider can help you track where new options like Roxus fit as the data comes in.